AHA steps back from Bayer branding

There’s been a misleading association between Bayer and the American Heart Association — one that the cardiovascular advocacy now deems a mistake, Kaiser Health News reports. The AHA allowed its logo onto advertising material for Bayer’s low-dose aspirin containers, implicating that one might reduce their heart attack risk by taking a “baby aspirin.”

New research is showing that may not be the case. In fact, the AHA is now saying that although aspirin might help those who have previously had cardiovascular events, the risks of taking the drug in a more general population might actually outweigh the benefits.

“This was a misstep,” an AHA spokesperson told Kaiser. “It was a human error on my end.”